Evidence-based recommendations on nintedanib (Ofev) for treating idiopathic pulmonary fibrosis in adults when forced vital capacity is above 80% predicted.
This technology appraisal is for treating idiopathic pulmonary fibrosis in people with a forced vital capacity (FVC) above 80% predicted. Nintedanib...
Kim, Tae-Han;
Kim, In-Ho;
Kang, Seung Joo;
Choi, Miyoung;
Kim, Baek-Hui;
Eom, Bang Wool;
Kim, Bum Jun;
Min, Byung-Hoon;
Choi, Chang In;
Shin, Cheol Min;
Tae, Chung Hyun;
Gong, Chung Sik;
Kim, Dong Jin;
Cho, Arthur Eung-Hyuck;
Gong, Eun Jeong;
Song, Geum Jong;
Im, Hyeon-Su;
Ahn, Hye Seong;
Lim, Hyun;
Kim, Hyung-Don;
Kim, Jae-Joon;
Yu, Jeong Il;
Lee, Jeong Won;
Park, Ji Yeon;
Kim, Jwa Hoon;
Song, Kyoung Doo;
Jung, Minkyu;
Jung, Mi Ran;
Son, Sang-Yong;
Park, Shin-Hoo;
Kim, Soo Jin;
Lee, Sung Hak;
Kim, Tae-Yong;
Bae, Woo Kyun;
Koom, Woong Sub;
Jee, Yeseob;
Kim, Yoo Min;
Kwak, Yoonjin;
Park, Young Suk;
Han, Hye Sook;
Nam, Su Youn;
Kong, Seong-Ho.
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group inclu...
This guideline presents evidence and recommendations for cervical ripening and induction of labour. It aims to provide information to birth attendants and pregnant individuals on optimal perinatal care while avoiding unnecessary obstetrical intervention. Consistent interprofessional use of the guideline,...
This systematic review provides a high-quality, comprehensive summary of recommendations on hypertension (HT) and type 2 diabetes mellitus (T2DM), accentuating patient blood pressure, HbA1c levels, patterns of drug treatment, management, and screening of these diseases. The overall objective of the revie...
Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.
Commercial arrangement
There is a simple discount patient access scheme for maribavir. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisat...
Evidence-based recommendations on trabeculectomy with a biodegradable collagen matrix implant for glaucoma. This involves cutting a small flap in the white of the eye and putting a patch over the flap to help healing and prevent scarring. Fluid slowly drains out of the flap and the patch dissolves over t...
NICE is unable to make a recommendation on angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock. This is because Paion AG did not provide an evidence submission. We will review this decision if the company decides to make a submission....
This guidance replaces the NICE medtech innovation briefing on LiverMultiScan for liver disease (MIB181).
Your responsibility
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expecte...
Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.
Commercial arrangements
There is a simple discount patient access scheme for lenvatinib and a commercial access agreement for pembrolizumab. NHS organisations can g...
Evidence-based recommendations on laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux disease. This involves placing a ring of beads outside of the food pipe, just above the stomach. Magnets inside the beads hold them together to keep the food pipe closed but are weak enough to move a...
